WallStreetZenWallStreetZen

NASDAQ: VREX
Varex Imaging Corp Stock Forecast, Predictions & Price Target

Analyst price target for VREX

Based on 1 analyst offering 12 month price targets for Varex Imaging Corp.
Min Forecast
$30.00+72.41%
Avg Forecast
$30.00+72.41%
Max Forecast
$30.00+72.41%

Should I buy or sell VREX stock?

Based on 1 analyst offering ratings for Varex Imaging Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VREX stock forecasts and price targets.

VREX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-15

1 of 1

Forecast return on equity

Is VREX forecast to generate an efficient return?
Company
N/A
Industry
20.28%
Market
28.98%

Forecast return on assets

Is VREX forecast to generate an efficient return on assets?
Company
N/A
Industry
10.63%

VREX revenue forecast

What is VREX's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$852.9M-2.84%
Avg 2 year Forecast
$894.8M+1.94%
VREX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VREX revenue growth forecast

How is VREX forecast to perform vs Medical Devices companies and vs the US market?
Company
-2.84%
Industry
8.12%
Market
13.57%
VREX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VREX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VREX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VREX$17.40$30.00+72.41%Buy
SILK$18.05$20.80+15.24%Buy
KIDS$30.45$37.17+22.06%Buy
TMCI$11.88$13.67+15.04%Strong Buy
QTRX$17.15$32.00+86.59%Buy

Varex Imaging Stock Forecast FAQ

Is Varex Imaging Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VREX) stock is to Buy VREX stock.

Out of 1 analyst, 0 (0%) are recommending VREX as a Strong Buy, 1 (100%) are recommending VREX as a Buy, 0 (0%) are recommending VREX as a Hold, 0 (0%) are recommending VREX as a Sell, and 0 (0%) are recommending VREX as a Strong Sell.

If you're new to stock investing, here's how to buy Varex Imaging stock.

What is VREX's revenue growth forecast for 2024-2025?

(NASDAQ: VREX) Varex Imaging's forecast annual revenue growth rate of -2.84% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.57%.

Varex Imaging's revenue in 2024 is $877,800,000.On average, 2 Wall Street analysts forecast VREX's revenue for 2024 to be $34,114,000,000, with the lowest VREX revenue forecast at $34,112,000,000, and the highest VREX revenue forecast at $34,116,000,000.

In 2025, VREX is forecast to generate $35,792,000,000 in revenue, with the lowest revenue forecast at $35,664,000,000 and the highest revenue forecast at $35,920,000,000.

What is VREX's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: VREX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.63%.

What is VREX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VREX price target, the average VREX price target is $30.00, with the highest VREX stock price forecast at $30.00 and the lowest VREX stock price forecast at $30.00.

The Wall Street analyst predicted that Varex Imaging's share price could reach $30.00 by Nov 15, 2024. The average Varex Imaging stock price prediction forecasts a potential upside of 72.41% from the current VREX share price of $17.40.

What is VREX's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: VREX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.